Rigel Pharmaceuticals, Inc.
USD40.54
-1.13 (-2.71%)
CEO
Raul R. Rodriguez
IPO Date
2000-11-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$41.45
Prev. Close
$41.67
Day Low
$40.49
Day High
$42.00
52W Low
$18.80
52W High
$52.24
Market Cap
$0.75B
Volume
0.20M
| 2,500 |
| $35.00 |
| 22 Jun 2026 | Furey Raymond J. | EVP, GC, CCO & Corp Sec | A-Award | Acquired | 7,394 | $22.49 |
| 22 Jun 2026 | RODRIGUEZ RAUL R | director, officer: CEO, President | A-Award | Acquired | 31,700 | $22.49 |
| 22 Jun 2026 | Rojkjaer Lisa | EVP, Chief Medical Officer | A-Award | Acquired | 9,375 | $14.90 |
| 22 Jun 2026 | Rojkjaer Lisa | EVP, Chief Medical Officer | A-Award | Acquired | 7,394 | $22.49 |
| 22 Jun 2026 | Santos David A | EVP, Chief Commercial Officer | A-Award | Acquired | 7,394 | $22.49 |
| 22 Jun 2026 | Schorno Dean L | EVP & Chief Financial Officer | A-Award | Acquired | 7,394 | $22.49 |
| 3 Jun 2026 | Schorno Dean L | EVP & Chief Financial Officer | M-Exempt | Acquired | 2,181 | $12.70 |
| 3 Jun 2026 | Schorno Dean L | EVP & Chief Financial Officer | F-InKind | Disposed | 928 | $29.86 |